Infection de l’adulte à Parvovirus

Jacquot, Robin; Gerfaud‐Valentin, Mathieu; Mekki, Yahia; Billaud, Geneviève; Jamilloux, Yvan; Sève, P.

doi:10.1016/j.revmed.2022.08.005

Cited by 4 publications

(2 citation statements)

References 148 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Parvovirus B19 is a ubiquitous virus whose exclusive host is humans [7]. In temperate zones, it is responsible for endemics and epidemics in late winter and early spring approximately every four years [8].…”

Section: Discussionmentioning

confidence: 99%

The Seroprevalence of Parvovirus B19 at the Laboratory of Virology of IBN Sina Rabat University Hospital

Zahid,

Zouaki,

Tazi

et al. 2024

Cross Current Int J Med Biosci

View full text Add to dashboard Cite

Parvovirus B19 (PVB19) is a DNA virus whose main tropism is erythroid precursors, it is responsible for infections that can be life-threatening in fetuses and immunocompromised individuals. The aim of this study was to determine the seroprevalence of Parvovirus B19 in a Moroccan population. We conducted a retrospective study between March 2019 and July 2022 at the Central Laboratory of Virology of Ibn Sina University Hospital of Rabat. All included samples were qualitatively tested for parvovirus B19 anti-VP2 IgG by ELISA on the Chorus analyzer (Diesse diagnostic). Of the 343 patients included, 181 (53%) were women. 165 (48%) were adults with an average age of 45 years [17 - 89], while 178 (52%) were children with an average age of 6 years [0.7 - 16]. Anti-PVB19 IgG were positive in 166 patients, giving an overall seroprevalence of 48.4%. The latter was significantly higher in adults (63.1% vs. 34.8%; p= <0.001) and increased significantly with age, from 32.5% in children aged [7 months to 5 years], to 65.1% in patients over 35 years (p= <0.001). Gender had no impact on seroprevalence. Our study showed an overall seroprevalence of parvovirus B19 of 48.4%. Seroprevalence increased significantly with age, which aligns with the findings in the literature. No previous data in Morocco.

show abstract

Section: Discussionmentioning

confidence: 99%

The Seroprevalence of Parvovirus B19 at the Laboratory of Virology of IBN Sina Rabat University Hospital

Zahid,

Zouaki,

Tazi

et al. 2024

Cross Current Int J Med Biosci

View full text Add to dashboard Cite

show abstract

“…Infection of pregnant women can cause in-utero death. Seasonal outbreaks of B19V are known to occur every 3–4 years in late winter and early spring [ 1 ].…”

mentioning

confidence: 99%

An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024

d’Humières,

Fouillet,

Verdurme

et al. 2024

Eurosurveillance

View full text Add to dashboard Cite

From April 2023 to May 2024, an unusual epidemic of parvovirus B19 (B19V) infections occurred in France. The number of B19V IgM-positive serologies was four times higher than in the previous epidemic in 2019. Clinical data from emergency networks corroborated this observation. Morbidity and mortality consequences were observed in children through all data sources. In adults, the increase was only observed in laboratory-confirmed data. Physicians and decisionmakers should be informed in order to better prevent, diagnose and manage at-risk patients.

show abstract

L’érythroblastopénie : diagnostic, classification, traitement

Lobbes

2023

La Revue de Médecine Interne

View full text Add to dashboard Cite

Infection de l’adulte à Parvovirus

Cited by 4 publications

References 148 publications

The Seroprevalence of Parvovirus B19 at the Laboratory of Virology of IBN Sina Rabat University Hospital

The Seroprevalence of Parvovirus B19 at the Laboratory of Virology of IBN Sina Rabat University Hospital

An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024

L’érythroblastopénie : diagnostic, classification, traitement

Contact Info

Product

Resources

About